{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:17:10Z","timestamp":1787170630782,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1002\/jps.24473","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T17:41:47Z","timestamp":1431366107000},"page":"2276-2284","source":"Crossref","is-referenced-by-count":15,"title":["Targeted Delivery of NK007 to Macrophages to Treat Colitis"],"prefix":"10.1016","volume":"104","author":[{"given":"Siming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.24473_bb0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1002\/jps.24473_bb0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: Mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1002\/jps.24473_bb0015","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jps.24473_bb0020","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1002\/jps.24473_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.12221","article-title":"Macrophage proliferation, provenance, and plasticity in macroparasite infection","volume":"262","author":"Ruckerl","year":"2014","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1002\/jps.24473_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12192","article-title":"Macrophages in intestinal homeostasis and inflammation","volume":"260","author":"Bain","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1002\/jps.24473_bb0035","first-page":"18","article-title":"Macrophage subsets in immune-mediated inflammatory disease: Lessons from rheumatoid arthritis, spondyloarthritis, osteoarthritis, Behfet\u2019s disease and gout","volume":"3","author":"Lebre","year":"2010","journal-title":"Open Arthritis J"},{"key":"10.1002\/jps.24473_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2013\/948976","article-title":"The benefits and detriments of macrophages\/microglia in models of multiple sclerosis","volume":"2013","author":"Rawji","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1002\/jps.24473_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1002\/jps.24473_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1002\/jps.24473_bb0055","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1158\/0008-5472.CAN-06-1278","article-title":"Macrophages regulate the angiogenic switch in a mouse model of breast cancer","volume":"66","author":"Lin","year":"2006","journal-title":"Cancer Res"},{"issue":"7446","key":"10.1002\/jps.24473_bb0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1002\/jps.24473_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1381612033391982","article-title":"Anti-TNF therapy for Crohn\u2019s disease","volume":"9","author":"D\u2019Haens","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1002\/jps.24473_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J Pathol"},{"key":"10.1002\/jps.24473_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jps.24473_bb0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/eci.10.45","article-title":"Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease","volume":"6","author":"Shah","year":"2010","journal-title":"Expert Rev Clin Immu"},{"key":"10.1002\/jps.24473_bb0085","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"10.1002\/jps.24473_bb0090","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2174\/138161211798157658","article-title":"Anti-TNF treatment in rheumatoid arthritis","volume":"17","author":"Geiler","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1002\/jps.24473_bb0095","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.24473_bb0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2036.2010.04531.x","article-title":"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab","volume":"33","author":"Taxonera","year":"2011","journal-title":"Aliment Pharm Therap"},{"key":"10.1002\/jps.24473_bb0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.intimp.2012.08.008","article-title":"A novel tylophorine analog NK-007 ameliorates colitis through inhibition of innate immune response","volume":"14","author":"Wen","year":"2012","journal-title":"Int Im- munopharmacol"},{"key":"10.1002\/jps.24473_bb0110","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/art.34528","article-title":"Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor a production and Th17 cell differentiation","volume":"64","author":"Wen","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5\u20136","key":"10.1002\/jps.24473_bb0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000339153","article-title":"Particulate systems for targeting of macrophages: Basic and therapeutic concepts","volume":"4","author":"Moghimi","year":"2012","journal-title":"J Innate Immun"},{"issue":"8","key":"10.1002\/jps.24473_bb0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1002\/jps.24473_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/14737159.2013.819216","article-title":"Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease","volume":"13","author":"Lameijer","year":"2013","journal-title":"Expert Rev Mol Diagn"},{"issue":"35","key":"10.1002\/jps.24473_bb0130","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1016\/j.biomaterials.2005.05.044","article-title":"Therapeutic potential of nanoparticulate systems for macrophage targeting","volume":"26","author":"Chellata","year":"2005","journal-title":"Biomaterials"},{"key":"10.1002\/jps.24473_bb0135","first-page":"17","article-title":"Macrophages targeted drug delivery as a key therapy in infectious disease","volume":"2","author":"Alexandra","year":"2014","journal-title":"Biotechnol Mol Biol Nanomed"},{"issue":"9","key":"10.1002\/jps.24473_bb0140","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/mp400216r","article-title":"Targeting of tumor- associated macrophages made possible by PEG-sheddable, mannose- modified nanoparticles","volume":"10","author":"Zhu","year":"2013","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"10.1002\/jps.24473_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2013.04.030","article-title":"Preparation, macrophages targeting delivery and antiinflammatory study of penta-peptide grafted nanostructured lipid carriers","volume":"450","author":"Zhao","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.24473_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1993.tb03678.x","article-title":"Fc-receptor-mediated targeting of antibody-bearing liposomes containing dideoxycytidine triphosphate to human monocyte\/macrophages","volume":"45","author":"Betageri","year":"1993","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"10.1002\/jps.24473_bb0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J"},{"issue":"6\u20137","key":"10.1002\/jps.24473_bb0160","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1051\/medsci\/20082467659","article-title":"Oral bioavailability and drug\/carrier particulate systems","volume":"24","author":"Wawrezinieck","year":"2008","journal-title":"Med Sci (Paris)"},{"issue":"2","key":"10.1002\/jps.24473_bb0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biomaterials.2010.09.037","article-title":"The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen","volume":"32","author":"Jain","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"10.1002\/jps.24473_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J Control Release"},{"issue":"36","key":"10.1002\/jps.24473_bb0175","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"issue":"3","key":"10.1002\/jps.24473_bb0180","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cocis.2010.12.005","article-title":"Fate of polymeric nanocarriers for oral drug delivery","volume":"16","author":"Plapied","year":"2011","journal-title":"Curr Opin Colloid In"},{"key":"10.1002\/jps.24473_bb0185","unstructured":"GRN No. 239. Accessed, at: http:\/\/www.accessdata.fda.gov\/scripts\/fdcc\/?set=GRASNotices."},{"issue":"12","key":"10.1002\/jps.24473_bb0190","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.molimm.2003.10.007","article-title":"Dectin-1 and its role in the recognition of beta-glucans by macrophages","volume":"40","author":"Herre","year":"2004","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1002\/jps.24473_bb0195","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1021\/bc700329p","article-title":"Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery","volume":"19","author":"Soto","year":"2008","journal-title":"Bioconjugate Chem"},{"issue":"2","key":"10.1002\/jps.24473_bb0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/jimmunol.173.2.797","article-title":"Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models","volume":"173","author":"Hong","year":"2004","journal-title":"J Immunol"},{"issue":"38","key":"10.1002\/jps.24473_bb0205","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1039\/c1cc14019a","article-title":"Yeast cell wall particles: A promising class of nature-inspired microcarriers for multimodal imaging","volume":"47","author":"Figueiredo","year":"2011","journal-title":"Chem Commun"},{"issue":"7242","key":"10.1002\/jps.24473_bb0210","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nature07774","article-title":"Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation","volume":"458","author":"Aouadi","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1002\/jps.24473_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20110352","article-title":"GMPs for selective delivery of siRNA to phagocytic cells in mice","volume":"436","author":"Tesz","year":"2011","journal-title":"Biochem J"},{"issue":"1","key":"10.1002\/jps.24473_bb0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4049\/jimmunol.1200603","article-title":"Relative contributions of dectin-1 and complement to immune responses to particulate $-glucans","volume":"189","author":"Huang","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"10.1002\/jps.24473_bb0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jconrel.2013.09.007","article-title":"\u03b2-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination","volume":"172","author":"Smet","year":"2013","journal-title":"J Control Release"},{"key":"10.1002\/jps.24473_bb0230","first-page":"1743","article-title":"Specifically targeted delivery of protein to phagocytic macrophages","volume":"10","author":"Yu","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1002\/jps.24473_bb0235","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/jf902543r","article-title":"Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives","volume":"58","author":"Wang","year":"2010","journal-title":"J Agric Food Chem"},{"key":"10.1002\/jps.24473_bb0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-59745-396-7_14","article-title":"Generation, culture and flow- cytometric characterization of primary mouse macrophages","volume":"531","author":"Schleicher","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1002\/jps.24473_bb0245","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","article-title":"A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice","volume":"98","author":"Okayasu","year":"1990","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/jps.24473_bb0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.ejcn.1601160","article-title":"Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men","volume":"55","author":"Battilana","year":"2001","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"10.1002\/jps.24473_bb0255","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ajcn\/78.4.711","article-title":"Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men","volume":"78","author":"Keogh","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1002\/jps.24473_bb0260","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1172\/JCI30602","article-title":"TREM-1- expressing intestinal macro-phages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases","volume":"117","author":"Schenk","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1002\/jps.24473_bb0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2249.2010.04234.x","article-title":"Use of bioluminescence imaging to track neutrophil migration and its inhibition in experimental colitis","volume":"162","author":"Murphy","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1002\/jps.24473_bb0270","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.cr.7310009","article-title":"Inflammatory bowel disease requires the interplay between innate and adaptive immune signals","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915300538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915300538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T19:39:37Z","timestamp":1566675577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915300538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0022354915300538"],"URL":"https:\/\/doi.org\/10.1002\/jps.24473","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}